Full article: Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study
Vaccines | Free Full-Text | Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
A different take on swine influenza vaccination - Articles - pig333, pig to pork community
Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection - ScienceDirect
Progressis - Products - Ceva Santé Animale - pig333, pig to pork community
COVID-19 Vaccination Strategies: When Is One Dose Better Than Two? - AIP Publishing LLC
Vaccines | Free Full-Text | Heterologous Prime-Boost Vaccination with Inactivated Influenza Viruses Induces More Effective Cross-Protection than Homologous Repeat Vaccination
Is prime boost strategy a promising approach in HIV vaccine development | Semantic Scholar
Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines
JCI - Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas
Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice | PLOS ONE
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
Cancers | Free Full-Text | Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
Full article: Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates
Frontiers | Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy - eBioMedicine
Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice | Signal Transduction and Targeted Therapy
Decisive Conditions for Strategic Vaccination against SARS-CoV-2 | medRxiv
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine
Frontiers | Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines | Journal of Molecular Medicine
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 | npj Vaccines
